Two Sigma Advisers’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-73,100
| Closed | -$1.75M | – | 2821 |
|
|
2021
Q1 | $1.75M | Sell |
73,100
-165,900
| -69% | -$3.96M | ﹤0.01% | 1335 |
|
|
2020
Q4 | $3.49M | Sell |
239,000
-370,300
| -61% | -$5.41M | 0.01% | 977 |
|
|
2020
Q3 | $8.65M | Buy |
609,300
+347,300
| +133% | +$4.93M | 0.02% | 584 |
|
|
2020
Q2 | $3.85M | Buy |
262,000
+46,700
| +22% | +$687K | 0.01% | 898 |
|
|
2020
Q1 | $887K | Sell |
215,300
-48,600
| -18% | -$200K | ﹤0.01% | 1555 |
|
|
2019
Q4 | $1.27M | Buy |
263,900
+10,800
| +4% | +$51.9K | ﹤0.01% | 1453 |
|
|
2019
Q3 | $1.53M | Buy |
253,100
+18,500
| +8% | +$112K | ﹤0.01% | 1226 |
|
|
2019
Q2 | $1.52M | Buy |
234,600
+17,700
| +8% | +$115K | ﹤0.01% | 1328 |
|
|
2019
Q1 | $1.54M | Buy |
216,900
+72,500
| +50% | +$514K | ﹤0.01% | 1333 |
|
|
2018
Q4 | $702K | Sell |
144,400
-6,700
| -4% | -$32.6K | ﹤0.01% | 1643 |
|
|
2018
Q3 | $1.11M | Buy |
151,100
+5,400
| +4% | +$39.7K | ﹤0.01% | 1470 |
|
|
2018
Q2 | $930K | Buy |
145,700
+29,800
| +26% | +$190K | ﹤0.01% | 1636 |
|
|
2018
Q1 | $630K | Sell |
115,900
-32,400
| -22% | -$176K | ﹤0.01% | 1736 |
|
|
2017
Q4 | $618K | Buy |
+148,300
| New | +$618K | ﹤0.01% | 1707 |
|
|
2017
Q2 | – | Sell |
-41,800
| Closed | -$536K | – | 2458 |
|
|
2017
Q1 | $536K | Sell |
41,800
-1,400
| -3% | -$18K | ﹤0.01% | 1864 |
|
|
2016
Q4 | $529K | Sell |
43,200
-17,500
| -29% | -$214K | ﹤0.01% | 1853 |
|
|
2016
Q3 | $716K | Buy |
+60,700
| New | +$716K | ﹤0.01% | 1505 |
|
|
2015
Q3 | – | Sell |
-43,700
| Closed | -$396K | – | 2059 |
|
|
2015
Q2 | $396K | Buy |
43,700
+800
| +2% | +$7.25K | ﹤0.01% | 1519 |
|
|
2015
Q1 | $557K | Sell |
42,900
-15,600
| -27% | -$203K | ﹤0.01% | 1294 |
|
|
2014
Q4 | $796K | Buy |
+58,500
| New | +$796K | 0.01% | 1172 |
|
|
2014
Q3 | – | Sell |
-10,500
| Closed | -$142K | – | 2096 |
|
|
2014
Q2 | $142K | Buy |
+10,500
| New | +$142K | ﹤0.01% | 1796 |
|